Cell-permeable hypoxia-inducible factor-1 (HIF-1) antagonists function as tumor radiosensitizers

Medical Hypotheses

Volumn 69, Issue 1, 2007, Pages 33-35

  Shi, Mei ^a   Guo, Xiao Tong ^a   Shu, Mao Guo ^a   Chen, Fu Lin ^b   Li, Li Wen ^a,b  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b NORTHWEST UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; HYBRID PROTEIN; HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 1 INHIBITOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PROTEIN INHIBITOR; RADIOSENSITIZING AGENT; SURVIVIN; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; APOPTOSIS; ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CARBOXY TERMINAL SEQUENCE; CELL MEMBRANE PERMEABILITY; CELL METABOLISM; CELL PROLIFERATION; CELL SURVIVAL; GENE EXPRESSION; HUMAN; HYPOXIA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DOMAIN; RADIATION PROTECTION; RADIOSENSITIVITY; SIGNAL TRANSDUCTION; SOLID TUMOR; TREATMENT RESPONSE; TUMOR CELL; UPREGULATION; VASCULAR ENDOTHELIUM;

ANTINEOPLASTIC AGENTS; CELL HYPOXIA; CELL MEMBRANE PERMEABILITY; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; MODELS, BIOLOGICAL; NEOPLASMS; RADIATION-SENSITIZING AGENTS;

EID: 34247573392     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2006.10.062     Document Type: Article

References (20)

1. Bel Aiba R.S., Dimova E.Y., Gorlach A., and Kietzmann T. The role of hypoxia inducible factor-1 in cell metabolism - a possible target in cancer therapy. Expert Opin Ther Targets 10 4 (2006) 583-599
2. Melillo G. Inhibiting hypoxia-inducible factor 1 for cancer therapy. Mol Cancer Res 4 9 (2006) 601-605
3. Moeller B.J., and Dewhirst M.W. HIF-1 and tumour radiosensitivity. Brain J Cancer 95 1 (2006) 1-5
4. Ke Q., and Costa M. Hypoxia-inducible factor-1 (HIF-1). Mol Pharmacol 70 (2006) 1469-1480
5. Pouyssegur J., Dayan F., and Mazure N.M. Hypoxia signalling in cancer and approaches to enforce tumour regression. Nature 441 7092 (2006) 437-443
6. Kung A.L., Wang S., Klco J.M., Kaelin W.G., and Livingston D.M. Suppression of tumor growth through disruption of hypoxia-inducible transcription. Nat Med 6 12 (2000) 1335-1340
7. Harada H., Kizaka-Kondoh S., and Hiraoka M. Antitumor protein therapy; application of the protein transduction domain to the development of a protein drug for cancer treatment. Breast Cancer 13 1 (2006) 16-26
8. Noguchi H., and Matsumoto S. Protein transduction technology: a novel therapeutic perspective. Acta Med Okayama 60 1 (2006) 1-11
9. Sah N.K., Khan Z., Khan G.J., and Bisen P.S. Structural, functional and therapeutic biology of survivin. Cancer Lett 244 2 (2006) 164-171
10. McLaughlin N., Annabi B., Bouzeghrane M., et al. The Survivin-mediated radioresistant phenotype of glioblastomas is regulated by RhoA and inhibited by the green tea polyphenol (-)-epigallocatechin-3-gallate. Brain Res 1071 1 (2006) 1-9
11. Kami K., Doi R., Koizumi M., et al. Downregulation of survivin by siRNA diminishes radioresistance of pancreatic cancer cells. Surgery 138 2 (2005) 299-305
12. Rodel F., Hoffmann J., Distel L., et al. Survivin as a radioresistance factor, and prognostic and therapeutic target for radiotherapy in rectal cancer. Cancer Res 65 11 (2005) 4881-4887
13. Kappler M., Taubert H., Bartel F., et al. Radiosensitization, after a combined treatment of survivin siRNA and irradiation, is correlated with the activation of caspases 3 and 7 in a wt-p53 sarcoma cell line, but not in a mt-p53 sarcoma cell line. Oncol Rep 13 1 (2005) 167-172
14. Asanuma K., Kobayashi D., Furuya D., Tsuji N., Yagihashi A., and Watanabe N. A role for survivin in radioresistance of pancreatic cancer cells. Jpn J Cancer Res 93 9 (2002) 1057-1062
15. Yang L., Cao Z., Li F., et al. Tumor-specific gene expression using the survivin promoter is further increased by hypoxia. Gene Ther 11 15 (2004) 1215-1223
16. Baechle D., Fischer R., Cansier A., Brock R., and Kalbacher H. A postcolumn alkalinization procedure enhances the sensitivity of fluorescence detection of fluorescein-labeled substances in RP-HPLC. Anal Biochem 345 1 (2005) 161-163
17. Garcia-Barros M., Paris F., Cordon-Cardo C., et al. Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science 300 5622 (2003) 1155-1159
18. Hirota K., and Semenza G.L. Regulation of angiogenesis by hypoxia-inducible factor 1. Crit Rev Oncol Hemat 59 1 (2006) 15-26
19. Moeller B.J., Cao Y., Li C.Y., and Dewhirst M.W. Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: role of reoxygenation, free radicals, and stress granules. Cancer Cell 5 5 (2004) 429-441
20. Calvani M., Rapisarda A., Uranchimeg B., Shoemaker R.H., and Melillo G. Hypoxic induction of an HIF-1alpha-dependent bFGF autocrine loop drives angiogenesis in human endothelial cells. Blood 107 7 (2006) 2705-2712